124 Hereditary Fibrinogen Abnormalities Flashcards
Normal fibrinogen levels range from
150 to 350 mg/dL
1.5 to 4 g/L
Fibrinogen is an abundant protein, synthesized in the liver
Normal half-life of 3 to 5 days
In afibrinogenemia, the fibrinogen concentration is less than
Less than 20 mg/dL
In hypofibrinogenemia, the level is less than normal.
Affect the quantity of fibrinogen in circulation (afibrinogenemia and hypofibrinogenemia)
Type I fibrinogen disorders
Affect the quality of circulating fibrinogen (dysfibrinogenemia and hypodysfibrinogenemia)
Type II fibrinogen disorders
A rare disorder of hepatic biosynthesis of fibrinogen, inherited as an autosomal
recessive trait, with low levels of fibrinogen typically found in both parents.
Congenital afibrinogenemia
Umbilical cord bleeding may occur after birth. Later, bleeding may be from mucosal surfaces, into muscles, or into joints.
Spontaneous abortions are frequent.
Death is most often a result of intracranial hemorrhage.
Appears to be caused by abnormal intracellular hepatic storage of fibrinogen
Hereditary hypofibrinogenemia
Fibrinogen concentrate should be given to increase the plasma concentrations by at least
150 mg/dL
One gram of fibrinogen concentrate raises the plasma fibrinogen level by ______ in adults.
20 mg/dL
Cryoprecipitate typically contains _______ mg of fibrinogen per unit.
300 mg of fibrinogen per unit
Approximately 50% to 70% of the administered fibrinogen circulates after transfusion, and the biologic half-life of fibrinogen is 3 to 5 days.
The recommended initial dose of cryoprecipitate
1 unit of cryoprecipitate (300 mg of fibrinogen) per 5 kg of body weight
Patients should receive one-third of the initial loading dose daily as long as is necessary to sustain the fibrinogen level.
The production of structurally abnormal fibrinogen molecules with altered functional properties.
Inherited as an autosomal dominant trait.
Most patients are heterozygous but some are homozygous.
AR mga Type 1
Inherited dysfibrinogenemia
Refers to patients with low levels of circulating abnormal fibrinogen
Hypodysfibrinogenemia
Fibrinogen abnormalities usually affect one or more phases of fibrin formation:
- Impaired fibrinopeptide release
- Defective fibrin polymerization
- Defective cross-linking by factor XIIIa
An autosomal dominant trait in which there is progressive extracellular deposition of “amyloid” protein in the kidneys due, in some instances, to deposition of fragments of a structurally abnormal fibrinogen
Hereditary renal amyloidosis
Acquired dysfibrinogenemia
- Liver diseases (e.g. cirrhosis, chronic active liver disease, hepatoma, liver failure) are the main causes
- Paraproteinemia (e.g. monoclonal gammopathy)